This is part of a larger recall. The most authoritative record is FDA-PR / baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml-20mg-ml-single-2026-07-24.
Baxter Cefazolin in Dextrose Injection recalled for cardboard particles in solution
What this means
Baxter is recalling one lot of Cefazolin in Dextrose Injection (2G/100mL) used to treat bacterial infections because cardboard particles were found in the solution. The affected product was distributed between March and June 2025. No injuries have been reported so far.
- If your facility has Lot LD175708 (expiration 14-Feb-2027), stop using it immediately.
- Return all affected units to Baxter according to your facility's procedures.
- Contact Baxter Healthcare at 888-229-0001 (7 am–6 pm CT, Monday–Friday) for return instructions.
- Report any adverse events to FDA MedWatch at www.fda.gov/medwatch/report.htm or 1-800-332-1088.
Product photos
The agency's original wording
July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.Risk Statement: The use of the defective product has a
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml20mg-ml-singleMore Baxter recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.